These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 8546414

  • 1. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG, Leclerc C, Dériaud E, Schirmbeck R, Reimann J, Davis HL.
    Ann N Y Acad Sci; 1995 Nov 27; 772():64-76. PubMed ID: 8546414
    [Abstract] [Full Text] [Related]

  • 2. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein.
    Davis HL, Schirmbeck R, Reimann J, Whalen RG.
    Hum Gene Ther; 1995 Nov 27; 6(11):1447-56. PubMed ID: 8573617
    [Abstract] [Full Text] [Related]

  • 3. Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization.
    Fuller JT, Fuller DH, McCabe D, Haynes JR, Widera G.
    Ann N Y Acad Sci; 1995 Nov 27; 772():282-4. PubMed ID: 8546409
    [No Abstract] [Full Text] [Related]

  • 4. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.
    Schirmbeck R, Böhm W, Ando K, Chisari FV, Reimann J.
    J Virol; 1995 Oct 27; 69(10):5929-34. PubMed ID: 7666497
    [Abstract] [Full Text] [Related]

  • 5. Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses.
    Roh S, Lee YK, Ahn BY, Kim K, Moon A.
    Virus Res; 2001 Jan 27; 73(1):17-26. PubMed ID: 11163641
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
    Chow YH, Huang WL, Chi WK, Chu YD, Tao MH.
    J Virol; 1997 Jan 27; 71(1):169-78. PubMed ID: 8985336
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of transfection in the priming of cytotoxic T-cells by DNA-mediated immunization.
    Sbai H, Schneider J, Hill AV, Whalen RG.
    Vaccine; 2002 Aug 19; 20(25-26):3137-47. PubMed ID: 12163265
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C, Peng G, Jin X, Tang J, Chen Z.
    Clin Immunol; 2010 Nov 19; 137(2):190-8. PubMed ID: 20692873
    [Abstract] [Full Text] [Related]

  • 16. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen.
    Schirmbeck R, Zheng X, Roggendorf M, Geissler M, Chisari FV, Reimann J, Lu M.
    J Immunol; 2001 Jan 15; 166(2):1405-13. PubMed ID: 11145726
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization.
    Loirat D, Lemonnier FA, Michel ML.
    J Immunol; 2000 Oct 15; 165(8):4748-55. PubMed ID: 11035120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.